Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage

A. Migliore, L. Alekseeva, SR. Avasthi, RR. Bannuru, X. Chevalier, T. Conrozier, S. Crimaldi, GC. de Campos, D. Diracoglu, G. Gigliucci, G. Herrero-Beaumont, G. Iolascon, R. Ionescu, J. Jerosch, J. Lains, E. Maheu, S. Makri, N. Martusevich, M....

. 2023 ; 15 (-) : 1759720X221131604. [pub] 20230225

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Early stage of osteoarthritis (OA) is characterized by joint stiffness and pain as well as by subclinical structural changes that may affect cartilage, synovium, and bone. At the moment, the lack of a validated definition of early osteoarthritis (EOA) does not allow to make an early diagnosis and adopt a therapeutic strategy to slow disease progression. Also, no questionnaires are available to evaluate the early stage, and therefore this remains an unmet need. OBJECTIVE: Therefore, the purpose of the technical experts panel (TEP) of 'International Symposium of intra-articular treatment' (ISIAT) was to create a specific questionnaire to evaluate and monitor the follow-up and clinical progress of patients affected by early knee OA. DESIGN: The items for the Early Osteoarthritis Questionnaire (EOAQ) were identified according to the following steps: items generation, items reduction, and pre-test submission. METHODS: During the first step, literature has been reviewed and a comprehensive list of items about pain and function in knee EOA was drafted. Then, during the ISIAT (5th edition 2019), the draft has been discussed by the board, which reformulated, deleted, or subdivided some of the items. After the ISIAT symposium, the draft was submitted to 24 subjects affected by knee OA. A score based on the importance and the frequency was created and the items with a score ⩾0.75 were selected. After intermediate evaluation made by a sample of patients, the second and final version of the questionnaire EOAQ was submitted to the whole board for final analysis and acceptance in a second meeting (29 January 2021). RESULTS: After an exhaustive elaboration, the final version of the questionnaire contains two domains (Clinical Features and Patients Reported Outcome) with respectively 2 and 9 questions, for a total of 11 questions. Questions mainly explored the fields of early symptoms and patients reported outcomes. Marginally, the need of the symptoms treatment and the use of painkillers were investigated. CONCLUSIONS: Adoption of diagnostic criteria of early OA is strongly encouraged and a specific questionnaire for the whole management of the clinical features and patients' outcome might really improve the evolution of OA in the early stages of the disease, when the treatment is expected to be more effective.

Academic Department of Orthopaedics Hull and East Yorkshire NHS Trust Castle Hill Hospital Cottingham UK

Centre for Treatment Comparison and Integrative Analysis Division of Rheumatology Tufts Medical Centre Boston MA USA

Chirurgia Ortopedica Mininvasiva e Nuove Tecnologie Humanitas Research Hospital Castellanza Italy

Department of Emergency Medicine Dr Ram Manohar Lohia Hospital Lucknow India

Department of Experimental and Clinical Medicine University of Florence Florence Italy

Department of Family Medicine School of Kinesiology University Western Ontario Ontario ON Canada

Department of Internal Medicine and Rheumatology Sf Maria Hospital University of Medicine and Pharmacy 'Carol Davila' Bucharest Romania

Department of Medical and Surgical Specialties and Dentistry University of Campania 'L Vanvitelli' Caserta Italy

Department of Metabolic Diseases of Bone and Joints VA Nasonova Research Institute of Rheumatology Moscow Russian Federation

Department of Orthopaedics and Traumatology 'Policlinico Tor Vergata' Foundation Rome Italy

Department of Orthopaedics and Traumatology University of Campinas São Paulo Brazil

Department of Physical Medicine and Rehabilitation Division of Pain Medicine Istanbul University Istanbul Turkey

Department of Rheumatology Belorussian State Medical University Minsk Belarus

EUPATI Graduate and Patient Advocate Brussels Belgium

Institute of Rheumatology Prague Czech Republic

Joint and Bone Research Unit IIS Fundacion Jimenez Diaz UAM Madrid Spain

Orthopaedic Department Johanna Etienne Hospital Neuss Germany

Physical Rehabilitation Medicine Department Rovisco Pais Medical and Rehabilitation Centre Tocha Portugal

Rheumatology Department AP HP Saint Antoine Hospital Paris France

Rheumatology Unit San Pietro Fatebenefratelli Hospital Rome Italy

Rheumatology Unit San Pietro Fatebenefratelli Hospital Via Cassia 600 00189 Rome Italy

Service de Rhumatologie Hôpital Nord Franche Belfort France

Unit of Rheumatology Henri Mondor Hospital Créteil France

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002828
003      
CZ-PrNML
005      
20230421100131.0
007      
ta
008      
230413s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1759720X221131604 $2 doi
035    __
$a (PubMed)36860967
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Migliore, Alberto $u Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Via Cassia 600- 00189, Rome, Italy $1 https://orcid.org/0000000233976478
245    10
$a Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage / $c A. Migliore, L. Alekseeva, SR. Avasthi, RR. Bannuru, X. Chevalier, T. Conrozier, S. Crimaldi, GC. de Campos, D. Diracoglu, G. Gigliucci, G. Herrero-Beaumont, G. Iolascon, R. Ionescu, J. Jerosch, J. Lains, E. Maheu, S. Makri, N. Martusevich, M. Matucci-Cerinic, K. Pavelka, RJ. Petrella, R. Raman, U. Tarantino
520    9_
$a BACKGROUND: Early stage of osteoarthritis (OA) is characterized by joint stiffness and pain as well as by subclinical structural changes that may affect cartilage, synovium, and bone. At the moment, the lack of a validated definition of early osteoarthritis (EOA) does not allow to make an early diagnosis and adopt a therapeutic strategy to slow disease progression. Also, no questionnaires are available to evaluate the early stage, and therefore this remains an unmet need. OBJECTIVE: Therefore, the purpose of the technical experts panel (TEP) of 'International Symposium of intra-articular treatment' (ISIAT) was to create a specific questionnaire to evaluate and monitor the follow-up and clinical progress of patients affected by early knee OA. DESIGN: The items for the Early Osteoarthritis Questionnaire (EOAQ) were identified according to the following steps: items generation, items reduction, and pre-test submission. METHODS: During the first step, literature has been reviewed and a comprehensive list of items about pain and function in knee EOA was drafted. Then, during the ISIAT (5th edition 2019), the draft has been discussed by the board, which reformulated, deleted, or subdivided some of the items. After the ISIAT symposium, the draft was submitted to 24 subjects affected by knee OA. A score based on the importance and the frequency was created and the items with a score ⩾0.75 were selected. After intermediate evaluation made by a sample of patients, the second and final version of the questionnaire EOAQ was submitted to the whole board for final analysis and acceptance in a second meeting (29 January 2021). RESULTS: After an exhaustive elaboration, the final version of the questionnaire contains two domains (Clinical Features and Patients Reported Outcome) with respectively 2 and 9 questions, for a total of 11 questions. Questions mainly explored the fields of early symptoms and patients reported outcomes. Marginally, the need of the symptoms treatment and the use of painkillers were investigated. CONCLUSIONS: Adoption of diagnostic criteria of early OA is strongly encouraged and a specific questionnaire for the whole management of the clinical features and patients' outcome might really improve the evolution of OA in the early stages of the disease, when the treatment is expected to be more effective.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Alekseeva, Liudmila $u Department of Metabolic Diseases of Bone and Joints, VA Nasonova Research Institute of Rheumatology, Moscow, Russian Federation
700    1_
$a Avasthi, Sachin R $u Department of Emergency Medicine, Dr Ram Manohar Lohia Hospital, Lucknow, India
700    1_
$a Bannuru, Raveendhara R $u Centre for Treatment Comparison and Integrative Analysis Division of Rheumatology, Tufts Medical Centre, Boston, MA, USA
700    1_
$a Chevalier, Xavier $u Unit of Rheumatology, Henri Mondor Hospital, Créteil, France
700    1_
$a Conrozier, Thierry $u Service de Rhumatologie, Hôpital Nord Franche, Belfort, France
700    1_
$a Crimaldi, Sergio $u Chirurgia Ortopedica Mininvasiva e Nuove Tecnologie, Humanitas Research Hospital, Castellanza, Italy
700    1_
$a de Campos, Gustavo C $u Department of Orthopaedics and Traumatology, University of Campinas, São Paulo, Brazil
700    1_
$a Diracoglu, Demirhan $u Department of Physical Medicine and Rehabilitation Division of Pain Medicine, Istanbul University, Istanbul, Turkey
700    1_
$a Gigliucci, Gianfranco $u Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy
700    1_
$a Herrero-Beaumont, Gabriel $u Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain $1 https://orcid.org/000000023241991X
700    1_
$a Iolascon, Giovanni $u Department of Medical and Surgical Specialties and Dentistry, University of Campania 'L Vanvitelli', Caserta, Italy $1 https://orcid.org/000000020976925X
700    1_
$a Ionescu, Ruxandra $u Department of Internal Medicine and Rheumatology Sf. Maria Hospital, University of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania
700    1_
$a Jerosch, Jörg $u Orthopaedic Department, Johanna Etienne Hospital, Neuss, Germany
700    1_
$a Lains, Jorge $u Physical Rehabilitation Medicine Department, Rovisco Pais Medical and Rehabilitation Centre, Tocha, Portugal
700    1_
$a Maheu, Emmanuel $u Rheumatology Department, AP-HP, Saint-Antoine Hospital, Paris, France
700    1_
$a Makri, Souz $u EUPATI Graduate and Patient Advocate, Brussels, Belgium
700    1_
$a Martusevich, Natalia $u Department of Rheumatology, Belorussian State Medical University, Minsk, Belarus
700    1_
$a Matucci-Cerinic, Marco $u Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
700    1_
$a Pavelka, Karen $u Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Petrella, Robert J $u Department of Family Medicine, School of Kinesiology University Western Ontario, Ontario, ON, Canada
700    1_
$a Raman, Raghu $u Academic Department of Orthopaedics, Hull and East Yorkshire NHS Trust Castle Hill Hospital, Cottingham, UK
700    1_
$a Tarantino, Umberto $u Department of Orthopaedics and Traumatology, 'Policlinico Tor Vergata' Foundation, Rome, Italy
773    0_
$w MED00203334 $t Therapeutic advances in musculoskeletal disease $x 1759-720X $g Roč. 15, č. - (2023), s. 1759720X221131604
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36860967 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421100124 $b ABA008
999    __
$a ok $b bmc $g 1922679 $s 1189035
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c - $d 1759720X221131604 $e 20230225 $i 1759-720X $m Therapeutic advances in musculoskeletal disease $n Ther Adv Musculoskelet Dis $x MED00203334
LZP    __
$a Pubmed-20230413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...